Global Antibiotics Market Size To Worth USD 72.01 Billion By 2033 | CAGR of 4.10%
Category: HealthcareGlobal Antibiotics Market Size To Worth USD 72.01 Billion By 2033
According to a research report published by Spherical Insights & Consulting, the Global Antibiotics Market Size is to Grow from USD 48.2 Billion in 2023 to USD 72.01 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 4.10% during the projected period.
Get more details on this report -
Browse key industry insights spread across 184 pages with 120 Market data tables and figures & charts from the report on the "Global Antibiotics Market Size, Share, and COVID-19 Impact Analysis, By Action Mechanism (Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA gyrase Inhibitors, RNA Synthesis Inhibitors), By Drug Class (Penicillin, Cephalosporin, Macrolide, Fluoroquinolones, Sulfonamide, Tetracycline, and Aminoglycoside), By Type (Branded, and Generic), By Application (Skin Infections, Respiratory Infections, Urinary Tract Infections, Septicemia, Ear Infection, Gastrointestinal Infections, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033. " Get Detailed Report Description Here:https://www.sphericalinsights.com/reports/antibiotics-market
Antibiotics are antimicrobial drugs that are used to treat and prevent bacterial illnesses by inhibiting the growth of the bacteria. Antibiotics treat bacterial infections by suppressing cell wall synthesis and, in some situations, disrupting DNA activity. Antibiotics are typically considered safe for both humans and animals. Antibiotics work in a variety of ways, including inhibiting bacterial cell wall construction, protein synthesis, DNA replication, and other essential bacterial processes. Antibiotics include penicillin, cephalosporin, macrolide, fluoroquinolones, sulfonamide, tetracycline, and aminoglycosides. Antibiotics are ineffective against viral infections, and their misuse or overuse can lead to antibiotic resistance, which occurs when bacteria develop to withstand the effects of the treatments designed to kill them. The global antibiotics market is fueled by a number of factors, including rising infectious disease prevalence, increased awareness and accessibility, advances in antibiotic therapy, and supporting government policies. The aging population and the increasing frequency of surgical procedures both contribute significantly to the demand for antibiotics. However, several issues limit the worldwide antibiotics industry, including the emergence of antibiotic-resistant microorganisms, tight regulatory requirements, and costly research and development costs. Furthermore, limited financial incentives, market saturation in developed nations, potential harmful side effects, and stricter laws on antibiotic usage in agriculture all impede market expansion.
The cell wall segment is anticipated to hold the greatest share of the global antibiotics market during the projected timeframe.
Based on the action mechanism, the global antibiotics market is divided into cell wall synthesis inhibitors, protein synthesis inhibitors, DNA gyrase inhibitors, and RNA synthesis inhibitors. Among these, the cell wall segment is anticipated to hold the greatest share of the global antibiotics market during the projected timeframe. The dominance of cell wall synthesis inhibitors in the worldwide antibiotics market is consistent with their extensive use and efficacy in treating bacterial infections. These antibiotics function by affecting the production of bacterial cell walls, weakening and eventually killing the bacteria. Penicillin and cephalosporins are two well-known cell wall synthesis inhibitors.
The cephalosporin segment is expected to grow the fastest CAGR growth during the projection period.
Based on the drug class, the global antibiotics market is categorized into penicillin, cephalosporin, macrolide, fluoroquinolones, sulfonamide, tetracycline, and aminoglycoside. Among these, the cephalosporin segment is expected to grow the fastest CAGR growth during the projection period. The cephalosporin segment of the global antibiotics market is expected to develop significantly as bacterial infections and antibiotic resistance rise. Ongoing research attempts to develop more effective and safer cephalosporins.
The generic segment is estimated to hold the largest market share of the global antibiotics market through the forecast period.
Based on the type, the global antibiotics market is categorized into branded, and generic. Among these, the generic segment is estimated to hold the largest market share of the global antibiotics market through the forecast period. The dominance of generics in the global antibiotics industry emphasizes the importance of price and accessibility in healthcare. Generic antibiotics, which contain the same active components as their brand-name equivalents, are often less expensive, making them more accessible to a larger audience. This affordability aspect is especially important in regions with low healthcare resources, increasing the choice of generic options.
The respiratory infections segment is predicted to hold the highest market share during the projected period.
Based on the application, the global antibiotics market is categorized into skin infections, respiratory infections, urinary tract infections, septicemia, ear infections, gastrointestinal infections, and others. Among these, the respiratory infections segment is predicted to hold the highest market share during the projected period. The respiratory infections category accounts for a considerable portion of the global antibiotics market, demonstrating the broad occurrence and severity of respiratory ailments around the world. Antibiotics play an important role in treating various infections, which range from pneumonia to sinusitis, by helping to remove the infection and ease symptoms.
The online segment is expected to have the largest market share through the forecast period.
Based on the distribution channel, the global antibiotics market is categorized into hospital pharmacies, retail pharmacies, and online pharmacies. Among these, the online segment is expected to have the largest market share through the forecast period. The expected domination of the online segment in the global antibiotics market reflects the growing trend of digitization in healthcare. Online pharmacies provide patients with ease and accessibility, allowing them to acquire antibiotics from home. The COVID-19 pandemic has accelerated the process.
North America is expected to hold the largest share of the global antibiotics market over the forecast period.
Get more details on this report -
North America is expected to hold the largest share of the global antibiotics market over the forecast period. This is due to the region's increasing prevalence of infectious diseases and higher government healthcare spending. Antibiotics are prescribed to treat bacterial diseases. They kill or prevent bacteria from growing, helping the body to eliminate illnesses.
Asia Pacific is predicted to grow at the fastest pace in the global antibiotics market during the projected timeframe. This expansion can be attributed to a number of factors, including increased healthcare infrastructure development, increased healthcare knowledge, and improved availability of antibiotics in the region. Furthermore, factors such as population growth, urbanization, and an increased prevalence of infectious diseases contribute to the demand for antibiotics in Asia Pacific.
Major key players in the global antibiotics market include Pfizer Inc., Novartis Ag, Sanofi, Cipla Inc., Lupin Pharmaceutics, Inc., Bayer AG, GSK Inc., Abbott, Torrent Pharma, Mylan N.V., AstraZeneca, Emcure Pharmaceuticals, Johnson & Johnson, Elli Lilly and Company, and others.
Recent Developments
- In January 2024, Orchid Pharma Ltd., a pharmaceutical company, announced that it had received approval from the European Medicines Agency to market its antibiotic 'Exblifeb,' the first completely invented-in-India Beta Lactamase inhibitor, to address the global challenge of antimicrobial resistance (AMR).
- In April 2023, Baxter International Inc. introduced ZOSYN (piperacillin and tazobactam) Injection in the US market.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global antibiotics market based on the below-mentioned segments:
Global Antibiotics Market, By Action Mechanism
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA gyrase Inhibitors
- RNA Synthesis Inhibitors
Global Antibiotics Market, By Drug Class
- Penicillin
- Cephalosporin
- Macrolide
- Fluoroquinolones
- Sulfonamide
- Tetracycline
- Aminoglycoside
Global Antibiotics Market, By Type
- Branded
- Generic
Global Antibiotics Market, By Application
- Skin Infections
- Respiratory Infections
- Urinary Tract Infections
- Septicemia
- Ear Infection
- Gastrointestinal Infections
- Others
Global Antibiotics Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Antibiotics Market, Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?